These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 27526263)

  • 1. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors.
    Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome.
    Pisani C; Gaillard JC; Odorico M; Nyalosaso JL; Charnay C; Guari Y; Chopineau J; Devoisselle JM; Armengaud J; Prat O
    Nanoscale; 2017 Feb; 9(5):1840-1851. PubMed ID: 27858044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zwitterionic polymer ligands: an ideal surface coating to totally suppress protein-nanoparticle corona formation?
    Debayle M; Balloul E; Dembele F; Xu X; Hanafi M; Ribot F; Monzel C; Coppey M; Fragola A; Dahan M; Pons T; Lequeux N
    Biomaterials; 2019 Oct; 219():119357. PubMed ID: 31351245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
    Xiao W; Gao H
    Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas.
    Portilla Y; Mellid S; Paradela A; Ramos-Fernández A; Daviu N; Sanz-Ortega L; Pérez-Yagüe S; Morales MP; Barber DF
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7924-7944. PubMed ID: 33587585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
    Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
    Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the nanoparticle-protein corona complexes using computational and experimental methods.
    Kharazian B; Hadipour NL; Ejtehadi MR
    Int J Biochem Cell Biol; 2016 Jun; 75():162-74. PubMed ID: 26873405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles.
    Su G; Jiang H; Xu B; Yu Y; Chen X
    Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Developments in the Design of Non-Biofouling Coatings for Nanoparticles and Surfaces.
    Sanchez-Cano C; Carril M
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
    Moraru C; Mincea M; Menghiu G; Ostafe V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatory interpretation of protein corona and shear stress for active cancer targeting of bioorthogonally clickable gelatin-oleic nanoparticles.
    Meghani NM; Amin H; Park C; Cui JH; Cao QR; Choi KH; Lee BJ
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110760. PubMed ID: 32279783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Functionalization of Nanoparticles for Generating Corona-Free and Noncytotoxic Silica Nanoparticles.
    Affonso de Oliveira JF; Scheffer FR; Landis RF; Teixeira Neto É; Rotello VM; Cardoso MB
    ACS Appl Mater Interfaces; 2018 Dec; 10(49):41917-41923. PubMed ID: 30426737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake.
    Mirshafiee V; Kim R; Park S; Mahmoudi M; Kraft ML
    Biomaterials; 2016 Jan; 75():295-304. PubMed ID: 26513421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
    Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
    Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research progress and application opportunities of nanoparticle-protein corona complexes.
    Huang W; Xiao G; Zhang Y; Min W
    Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein corona: a new approach for nanomedicine design.
    Nguyen VH; Lee BJ
    Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.